Molecular diagnostics currently has a crucial role in neuro-oncological patient care. (Epi)genetic assays testing for point mutations, copy number variations, gene fusions, translocations, and methylation status are of main diagnostic interest in neuro-oncology. Multiple assays have been developed for this purpose, ranging from single gene tests to high-Throughput, integrated techniques enabling detection of multiple genetic aberrations in a single workflow. This review describes the nature of the simpler and more complex assays for molecular diagnostics of tumors of the central nervous system and briefly discusses their strengths and weaknesses.
Priesterbach-Ackley, L. P., Wesseling, P., Snijders, T. J., de Vos, F. Y. F. L., & de Leng, W. W. J. (2019). Molecular tools for the pathologic diagnosis of central nervous system tumors. Neuro-Oncology Practice, 6(1), 4-16. https://doi.org/10.1093/nop/npy041